The Supreme Court has temporarily revoked the ban imposed on the sale of Saridon, an analgesic for headaches.
Saridon was one among 328 drugs, which were banned by the Central government recently. These were Fixed Dose Combinations (FDCs) which were banned by the Centre to stop irrational use.
A bench of Justice Rohinton Nariman and Justice Indu Malhotra temporarily allowed the sale of Saridon, and two other drugs after the drug makers challenged recent notification issued by the Centre prohibiting the manufacture and sale of 328 FDCs.
On September 7, the Ministry of Health and Family Welfare had issued a notification prohibiting the manufacture and sale of FDCs, which has a fixed dose combination of two or more compounds.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app